Invention Grant
- Patent Title: Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
- Patent Title (中): 11-β-羟基类固醇脱氢酶抑制剂1型
-
Application No.: US11598238Application Date: 2006-11-13
-
Publication No.: US08541592B2Publication Date: 2013-09-24
- Inventor: Martin Henriksson , Evert Homan , Lars Johansson , Jerk Vallgarda , Meredith Williams , Eric A. Bercot , Christopher H. Fotsch , Aiwen Li , Guolin Cai , Randall W. Hungate , Chester Chenguang Yuan , Christopher Tegley , David J. St. Jean, Jr. , Nianhe Han , Qi Huang , Qingyian Liu , Michael D. Bartberger , George A. Moniz , Matthew J. Frizzle , Teresa L. Marshall
- Applicant: Martin Henriksson , Evert Homan , Lars Johansson , Jerk Vallgarda , Meredith Williams , Eric A. Bercot , Christopher H. Fotsch , Aiwen Li , Guolin Cai , Randall W. Hungate , Chester Chenguang Yuan , Christopher Tegley , David J. St. Jean, Jr. , Nianhe Han , Qi Huang , Qingyian Liu , Michael D. Bartberger , George A. Moniz , Matthew J. Frizzle , Teresa L. Marshall
- Applicant Address: US CA Thousand Oaks SE Stockholm
- Assignee: Amgen Inc.,Biovitrum AB
- Current Assignee: Amgen Inc.,Biovitrum AB
- Current Assignee Address: US CA Thousand Oaks SE Stockholm
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61K31/4439 ; A61K31/426 ; A61K31/427 ; C07D277/60 ; C07D277/54 ; C07D417/02
Abstract:
The present invention relates to thiazolinones and also to pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human 11-β-hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme.
Public/Granted literature
- US20070197598A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Public/Granted day:2007-08-23
Information query
IPC分类:
